title: Conventional trial designs offer limited clinical understanding of cholinesterase-inhibitor treatment effects in Alzheimer disease.
authors.forename: Michael F
authors.initials: MF
authors.lastname: Shanks
authors.forename: Annalena
authors.initials: A
authors.lastname: Venneri
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000592:standards*
chemical_list: D002800:Cholinesterase Inhibitors